Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neckerman Indústria Farmacêutica (now operating as Onefarma or 1Farma) is a Brazilian pharmaceutical company that operates as a subsidiary of Grupo Cimed. The company specializes in the commercialization and distribution of generic and similar (branded generic) medicines in Brazil. Its product portfolio includes a wide range of small molecule therapeutics covering therapeutic areas such as cardiovascular health, infectious diseases, endocrinology, and pain management. All of its products are manufactured at Grupo Cimed's state-of-the-art manufacturing facility in Pouso Alegre, Minas Gerais, and registered under ANVISA regulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neckermann Industria Farmaceutica.